Percheron Therapeutics LimitedASX: PER

Orphan Drug designation from FDA for ATL1103 in Acromegaly

May 12, 2016 at 4:00 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment